Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (73)
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 • 9,986 citations
Principles of Bone Biology
2019 • 1,699 citations
Principles of Bone Biology
1997 • 1,367 citations
Integrins and anoikis
1997 • 1,145 citations
The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
1999 • 651 citations
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.
1994 • 527 citations
The αvβ3 integrin “vitronectin receptor”
1997 • 343 citations
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
1999 • 306 citations
Integrins and Angiogenesis
2004 • 290 citations
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
1997 • 287 citations
Role of αvβ3 integrin in osteoclast migration and formation of the sealing zone
1999 • 192 citations
Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA*
1994 • 190 citations
Bi-directional signal transduction by integrin receptors
2000 • 159 citations
Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury1:
1997 • 159 citations
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats
1998 • 122 citations
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic
1999 • 115 citations
Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) Antagonists
1997 • 114 citations
A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
1998 • 106 citations
Emerging Therapies for the Prevention or Treatment of Postmenopausal Osteoporosis
1998 • 106 citations
Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.
1999 • 100 citations
Vascular expression of the αvβ3-integrin in lung and other organs
2000 • 98 citations
Type II‘ to Type I β-Turn Swap Changes Specificity for Integrins
1996 • 96 citations
Binding of Abciximab to αVβ3 and Activated αMβ2 Receptors: With a Review of Platelet-Leukocyte Interactions
1999 • 96 citations
Potential non-glycoprotein IIb/IIIa effects of abciximab
1999 • 94 citations
Integrin antagonists
1999 • 86 citations
Isoxazolines as Potent Antagonists of the Integrin αvβ3
1999 • 85 citations
Novel Solid-Phase Synthesis of Azapeptides and Azapeptoides via Fmoc-Strategy and Its Application in the Synthesis of RGD-Mimetics
1999 • 85 citations
Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.
1996 • 80 citations
Reduction in Atherosclerotic Lesion Size in Pigs by αVβ3 Inhibitors Is Associated With Inhibition of Insulin-Like Growth Factor-I–Mediated Signaling
1999 • 78 citations
Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists
1996 • 71 citations
Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3
1999 • 71 citations
Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV
1997 • 70 citations
Solid-phase synthesis of a selective αvβ3 integrin antagonist library
1997 • 69 citations
Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor (α v β 3 ), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits
1999 • 68 citations
Design, synthesis and biological evaluation of nonpeptide integrin antagonists
1998 • 62 citations
Integrin cell adhesion receptors and the concept of agonism
2000 • 58 citations
Clinical management of rheumatoid arthritis
1993 • 58 citations
Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovariectomized Rat
2001 • 55 citations
Synthetic αVβ3 Antagonists Inhibit Insulin-Like Growth Factor-I-Stimulated Smooth Muscle Cell Migration and Replication1
1999 • 52 citations
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
1999 • 47 citations
Structure-Activity Relationships of Amino Acid-Containing lntegrin Antagonists
1999 • 46 citations
?v?3, ?v?5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation
1999 • 46 citations
Synthesis and Solution Conformation of Cyclo[RGDRGD]: A Cyclic Peptide with Selectivity for the αVβ3 Receptor
1996 • 40 citations
Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist.
1999 • 39 citations
Structure-activity relationships of beta-amino acid-containing integrin antagonists.
1999 • 36 citations
Reduced Intimal Thickening Following αvβ 3 Blockade is Associated with Smooth Muscle Cell Apoptosis
1998 • 36 citations
RGD Mimetics containing a central hydantoin scaffold: α V β 3 vs α IIb β 3 selectivity requirements
2000 • 35 citations
Vascular Indications for Integrin αv Antagonists
1997 • 34 citations
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model
1999 • 34 citations
A role for angiogenesis in rheumatoid arthritis
1999 • 33 citations
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats
1998 • 33 citations
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics
1999 • 30 citations
Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: Identification of αvβ3 antagonists lead compounds
1999 • 27 citations
Combinatorial Chemistry Techniques Applied to Nonpeptide lntegrin Antagonists
1998 • 27 citations
Synthesis and Biological Evaluation of Integrin Antagonists Containingtrans- andcis-2,5-Disubstituted THF Rings
2000 • 27 citations
Combinatorial chemistry techniques applied to nonpeptide integrin antagonists.
1998 • 27 citations
αvβ3 Integrin Binding Affinity and Specificity of SM256 in Various Species
1999 • 25 citations
Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat
1996 • 25 citations
Chapter 10. GPIIb/IIIa Antagonists
1996 • 25 citations
Arterial Wall Neovascularization
1997 • 24 citations
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists
1998 • 24 citations
Construction of a family of biphenyl combinatorial libraries: Structure-activity studies utilizing libraries of mixtures
1998 • 23 citations
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model
1998 • 21 citations
Sugar amino acids and carbohydrates as scaffolds and peptidomimetics
1999 • 21 citations
Synthesis and biological evaluation of dianhydrohexitol integrin antagonists
1999 • 17 citations
Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications
2000 • 14 citations
Section Review: Cardiovascular & Renal: Glycoprotein IIb/IIIa antagonists
1996 • 11 citations
Anti-integrins as a potential therapeutic target in angiogenesis
1999 • 11 citations
Liquid phase parallel synthesis of iminodiacetic acid derivatives
1999 • 8 citations
Synthetic V 3 Antagonists Inhibit Insulin-Like Growth Factor-I-Stimulated Smooth Muscle Cell Migration and Replication
1999 • 5 citations
Integrins and Angiogenesis
1999 • 2 citations
Inhibition of neointima formation by a nonpeptide ?v?3 integrin receptor antagonist in a rabbit cuff model
2000 • 2 citations
ChemInform Abstract: Sugar Amino Acids and Carbohydrates as Scaffolds and Peptidomimetics
2000 • 2 citations